Americans pay more for prescription drugs than anyone else, according to a new report, a single prescription of a hepatitis drug costs an uninsured person nearly $30,000.
According to a report published this month by Nice Rx, Americans spend about $1,011 per person each year, 25% more than the nearest country, and the cost of many drugs has doubled over the past decade.”
The most expensive drugs in the report were Harvoni, a hepatitis C drug manufactured by pharmaceutical giant Gilead and with an average prescription cost of $29,238 before insurance regulations, and Stelara, a psoriasis drug developed by J&J, 19,607.
One report claims that Harvoni costs $2 per pill to manufacture, which is usually around 84 in a single course, which is roughly 175 times the price averages according to the Nice Rx report.
The drug that went up in price the most was Humulin insulin, manufactured by Eli Lilly, whose price has risen by a staggering 1,070 percent over the past decade, making it one of four diabetes drugs that have soared in price over the past decade. Ten years. year at least doubled.
Neither Gilead, Johnson & Johnson or Eli Lilly answered a question from DailyMail.com about why the company believes the drugs should come at such a price.
According to Greg Jeffreys, an Australian hepatitis expert, the most expensive of the drugs, Harvoni costs $2 per pill, and each cycle of the drug contains about 80 pills.
The United States is notorious for high drug prices, with many on the other side pointing to the greed of the big pharmaceutical companies, intermediaries like pharmacists’ welfare managers, and too much and too little government regulation.
The United States spends more than $1,000 per person on prescription drugs, while Scandinavian countries like Norway and Sweden spend $401 and $351, respectively.
Of the ten countries included in the Nice Rx report, which includes the United States, Canada and eight European countries, Switzerland was the closest country to the United States in drug spending with 783 dollars per capita.
The researchers also collected the median prices for eight popular drugs and found that Americans paid 307% of the average drug price from 50 countries.
Insulin has long been the face of rising prices, and even President Joe Biden has said he will make cost-cutting a priority, as President Donald Trump has done for himself.

According to the report, the two insulins manufactured by Eli Lilly are among the drugs that have seen the largest price increases in the past decade.
Humulin is a neutral insulin that patients who take it regularly should control their diabetes. Without it, they can cause diabetic coma, loss of limbs, blindness, and even death.
From January 2012 to January 2022, the median price of the drug rose from $67 per prescription to $1,512.
However, it’s not the only type of insulin to see a huge price change over the past decade.
Humalog, another Eli Lilly product, rose 213% during this period from $126 to $623.
Other drugs that have seen price spikes include the kidney disease drug Renvela (made by Sanofi) with a 355% price increase, the pancreatic drug Creon (Abbvie) a 223% jump, as well as the menopause drug Premarin (Pfizer). . 215 percent.

Harvoni, made by Gilead, can cost the average $30,000 uninsured for a prescription.
Harvoni, the most expensive hepatitis drug, could be a concern right now as the rare kidney infection is starting to regrow worldwide, with nearly 200 cases discovered worldwide in the last few months.
Stelara was the only other drug in the report that cost more than $10,000 for the average prescription.
The top-paying state for prescription drugs is Texas, which pays its 29 million residents a total of $35.15 billion annually, above California, which pays $32.53 billion annually for its nearly 40 million residents.
Florida and New York, with the next two largest populations in the United States, also rank third and fourth in total drug spending.
Source: Daily Mail

I am Anne Johnson and I work as an author at the Fashion Vibes. My main area of expertise is beauty related news, but I also have experience in covering other types of stories like entertainment, lifestyle, and health topics. With my years of experience in writing for various publications, I have built strong relationships with many industry insiders. My passion for journalism has enabled me to stay on top of the latest trends and changes in the world of beauty.